Some traders have been critical of listed products designed to replicate OTC derivatives, but exchanges are working hard to develop appropriate listed instruments. Joel Clark reports.
Date
Contact us with immediate questions
Chicago
625 W. Adams, Suite 19-105
Chicago, IL 60661
